opdivocombotherapy.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Disallow: /servlet/* Sitemap:
Meta Tags
Title Dual I-O Therapy Efficacy | OPDIVO®
Description Set out towards a future dual I-O can Find information about OPDIVO® (nivolumab) + YERVOY® (ipilimumab) treatment in melanoma, RCC, and NSCLC. Please see Indications and Important Safety
Keywords N/A
Server Information
WebSite opdivocombotherapy faviconopdivocombotherapy.com
Host IP 165.89.235.20
Location United States
Related Websites
Site Rank
More to Explore
opdivocombotherapy.com Valuation
US$868
Last updated: 2023-05-01 06:48:50

opdivocombotherapy.com has Semrush global rank of 0. opdivocombotherapy.com has an estimated worth of US$ 868, based on its estimated Ads revenue. opdivocombotherapy.com receives approximately 100 unique visitors each day. Its web server is located in United States, with IP address 165.89.235.20. According to SiteAdvisor, opdivocombotherapy.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$868
Daily Ads Revenue US$0
Monthly Ads Revenue US$24
Yearly Ads Revenue US$288
Daily Unique Visitors 6
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
opdivocombotherapy.com. A 7198 IP: 165.89.235.20
opdivocombotherapy.com. NS 86400 NS Record: ns1.bms.com.
opdivocombotherapy.com. NS 86400 NS Record: ns4.bms.com.
opdivocombotherapy.com. NS 86400 NS Record: ns2.bms.com.
opdivocombotherapy.com. NS 86400 NS Record: ns3.bms.com.
opdivocombotherapy.com. TXT 86400 TXT Record: 3bms3jpch6vjk9qjlmh5d55pwx18bx6w
HtmlToTextCheckTime:2023-05-01 06:48:50
For U.S. Healthcare Professionals only. Full Prescribing Information OPDIVO Prescribing Information YERVOY Prescribing Information Opdualag Prescribing Information Medication Guide OPDIVO Medication Guide YERVOY Medication Guide Opdualag Medication Guide BMS Connect Patient Site --> SELECT INDICATION Non-Small Cell Lung Cancer (NSCLC) nsclc Metastatic/Recurrent or Early-Stage Neoadjuvant NSCLC (tumors ≥4 cm or node positive) Neoadjuvant NSCLC (tumors ≥4 cm or node positive) 1L mNSCLC (PD-L1 ≥1%) --> 1L mNSCLC (PD-L1 ≥1%) 1L mNSCLC (PD-L1 ≥1%) 1L r/m NSCLC (PD-L1 >1% & <1%) 1L r/m NSCLC (PD-L1 >1% & <1%) 2L mNSCLC 2L mNSCLC View All View All Renal Cell Carcinoma (RCC) rcc Advanced Intermediate or Poor Risk Advanced RCC Advanced RCC --> View All Advanced RCC Indications View All Advanced RCC Indications Gastroesophageal Cancers gastro Metastatic and Adjuvant Adjuvant Treatment of Completely Resected ESO or GEJ Cancer 1L Metastatic Gastric, GEJ, or Esophageal
HTTP Headers
HTTP/1.0 301 Moved Permanently
Location: http://www.opdivocombotherapy.com/
Server: BigIP
Connection: Keep-Alive
Content-Length: 0

HTTP/1.1 301 Moved Permanently
Date: Sat, 23 Oct 2021 22:08:05 GMT
Set-Cookie: CookieConsentPolicy=0:1; domain=na152.salesforce.com; path=/; expires=Sun, 23-Oct-2022 22:08:05 GMT; Max-Age=31536000
Cache-Control: no-cache,must-revalidate,max-age=0,no-store,private
Expires: Thu, 01 Jan 1970 00:00:00 GMT
X-Cnection: close
Set-Cookie: LSKey-c$CookieConsentPolicy=0:1; domain=na152.salesforce.com; path=/; expires=Sun, 23-Oct-2022 22:08:05 GMT; Max-Age=31536000
X-XSS-Protection: 1; mode=block
Content-Security-Policy: upgrade-insecure-requests
Location: https://www.opdivocombotherapy.com/
Connection: close

HTTP/1.1 200 OK
Date: Sat, 23 Oct 2021 22:08:05 GMT
Set-Cookie: CookieConsentPolicy=0:1; domain=na152.salesforce.com; path=/; expires=Sun, 23-Oct-2022 22:08:05 GMT; Max-Age=31536000
Cache-Control: public,max-age=600
X-Cnection: close
Set-Cookie: LSKey-c$CookieConsentPolicy=0:1; domain=na152.salesforce.com; path=/; expires=Sun, 23-Oct-2022 22:08:05 GMT; Max-Age=31536000
Strict-Transport-Security: max-age=31536004; includeSubDomains
X-XSS-Protection: 1; mode=block
Content-Security-Policy: upgrade-insecure-requests
X-Powered-By: Salesforce.com ApexPages
P3P: CP="CUR OTR STA"
Content-Language: en-US
Expires: Sat, 23 Oct 2021 22:18:05 GMT
Last-Modified: Sat, 23 Oct 2021 22:08:05 GMT
Content-Security-Policy: frame-ancestors 'self'
X-FRAME-OPTIONS: SAMEORIGIN
Content-Type: text/html;charset=UTF-8
Connection: close
opdivocombotherapy.com Whois Information
Domain Name: OPDIVOCOMBOTHERAPY.COM
Registry Domain ID: 2469069650_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: http://cscdbs.com
Updated Date: 2020-12-15T06:08:12Z
Creation Date: 2019-12-19T14:26:20Z
Registry Expiry Date: 2021-12-19T14:26:20Z
Registrar: CSC Corporate Domains, Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email: domainabuse@cscglobal.com
Registrar Abuse Contact Phone: 8887802723
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.BMS.COM
Name Server: NS2.BMS.COM
Name Server: NS3.BMS.COM
Name Server: NS4.BMS.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-12T07:24:01Z <<<